Advanced search
Publication Cover
Leukemia & Lymphoma Volume 46, 2005 - Issue 8
Submit an article Journal homepage
103
Views
23
CrossRef citations to date
0
Altmetric
Review

CD33 as a target of therapy in acute myeloid leukemia: current status and future perspectives

Wolfgang R Sperr Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria
,
Stefan Florian Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria
,
Alexander W Hauswirth Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria
&
Peter Valent Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, AustriaCorrespondence[email protected]
Pages 1115-1120 | Received 19 Mar 2005, Published online: 03 Aug 2009

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Raveen Stephen Stallon Illangeswaran, Saswati Das, Daniel Zechariah Paul, Vikram Mathews & Poonkuzhali Balasubramanian. (2019) A personalized approach to acute myeloid leukemia therapy: current options. Pharmacogenomics and Personalized Medicine 12, pages 167-179.
Read now
Ki-Seong Eom, Hee-Je Kim, Byung-Sik Cho, Su-Mi Choi, Dong-Gun Lee, Seung-Eun Lee, Seung-Ah Yahng, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong-Wook Lee, Chong-Won Park & Woo-Sung Min. (2011) Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia. Leukemia & Lymphoma 52:12, pages 2321-2328.
Read now

Articles from other publishers (21)

Shayan Rahmani, Niloufar Yazdanpanah & Nima Rezaei. (2022) Natural killer cells and acute myeloid leukemia: promises and challenges. Cancer Immunology, Immunotherapy 71:12, pages 2849-2867.
Crossref
Zhiyu Xia, Yu‐Ru Su, Paneen Petersen, Lihong Qi, Andre E. Kim, Jane C. Figueiredo, Yi Lin, Hongmei Nan, Lori C. Sakoda, Demetrius Albanes, Sonja I. Berndt, Stéphane Bézieau, Stephanie Bien, Daniel D. Buchanan, Graham Casey, Andrew T. Chan, David V. Conti, David A. Drew, Steven J. Gallinger, W. James Gauderman, Graham G. Giles, Stephen B. Gruber, Marc J. Gunter, Michael Hoffmeister, Mark A. Jenkins, Amit D. Joshi, Loic Le Marchand, Juan P. Lewinger, Li Li, Noralane M. Lindor, Victor Moreno, Neil Murphy, Rami Nassir, Polly A. Newcomb, Shuji Ogino, Gad Rennert, Mingyang Song, Xiaoliang Wang, Alicja Wolk, Michael O. Woods, Hermann Brenner, Emily White, Martha L. Slattery, Edward L. Giovannucci, Jenny Chang‐Claude, Paul D. P. Pharoah, Li Hsu, Peter T. Campbell & Ulrike Peters. (2020) Functional informed genome‐wide interaction analysis of body mass index, diabetes and colorectal cancer risk. Cancer Medicine 9:10, pages 3563-3573.
Crossref
Alireza Mirzaei, Zahra Madjd, Azade Amini Kadijani, Samaneh Alinaghi, Abolfazl Akbari & Gholamreza Tavoosidana. (2017) Cancer Stem Cell’s Potential Clinical Implications. Iranian Journal of Cancer Prevention In Press:In Press.
Crossref
Austin H. Chen & Ching-Heng Lin. (2011) A novel support vector sampling technique to improve classification accuracy and to identify key genes of leukaemia and prostate cancers. Expert Systems with Applications 38:4, pages 3209-3219.
Crossref
André Goy & Susan O’Brien. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases 47 66 .
Amer Zeidan & Meir Wetzler. 2010. Leukemias: Principles and Practice of Therapy. Leukemias: Principles and Practice of Therapy 1 16 .
Peter Valent, Sabine Cerny-Reiterer, Harald Herrmann, Irina Mirkina, Tracy I. George, Karl Sotlar, Wolfgang R. Sperr & Hans-Peter Horny. (2010) Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells. Best Practice & Research Clinical Haematology 23:3, pages 369-378.
Crossref
Edward D. Ball & H. Elizabeth Broome. (2010) Monoclonal antibodies in the treatment of hematologic malignancy. Best Practice & Research Clinical Haematology 23:3, pages 403-416.
Crossref
Heidrun Karlic, Harald Herrmann, Axel Schulenburg, Thomas W. Grunt, Sylvia Laffer, Irina Mirkina, Rainer Hubmann, Medhat Shehata, Brigitte Marian, Edgar Selzer, Michael Pfeilstöcker, Elisabeth Pittermann, Ulrich Jäger, Hubert Pehamberger, Christoph Zielinski & Peter Valent. (2010) Tumor-Stammzellforschung – Basis und Herausforderung für Diagnostik und TherapieTumor stem cell research – basis and challenge for diagnosis and therapy. Wiener klinische Wochenschrift 122:13-14, pages 423-436.
Crossref
Adam Abdool, Chen-Hsiung Yeh, Hagop Kantarjian, Susan O'Brien, Jean Marie Bruey, Francis Giles & Maher Albitar. (2010) Circulating CD33 and its clinical value in acute leukemia. Experimental Hematology 38:6, pages 462-471.
Crossref
Ashley Hamilton, Paolo Gallipoli, Emma Nicholson & Tessa L Holyoake. (2009) Targeted therapy in haematological malignancies. The Journal of Pathology 220:4, pages 404-418.
Crossref
Zhang Lei, Gui-Mei Zhang, Mei Hong, Zuo-Hua Feng & Bo Huang. (2009) Fusion of Dendritic Cells and CD34+CD38− Acute Myeloid Leukemia (AML) Cells Potentiates Targeting AML-initiating Cells by Specific CTL Induction. Journal of Immunotherapy 32:4, pages 408-414.
Crossref
N Misaghian, G Ligresti, L S Steelman, F E Bertrand, J Bäsecke, M Libra, F Nicoletti, F Stivala, M Milella, A Tafuri, M Cervello, A M Martelli & J A McCubrey. (2008) Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. Leukemia 23:1, pages 25-42.
Crossref
Jorge Castillo, Eric Winer & Peter Quesenberry. (2008) Newer monoclonal antibodies for hematological malignancies. Experimental Hematology 36:7, pages 755-768.
Crossref
James D. Hoyer, Karen L. Grogg, Curtis A. Hanson, Jeffrey D. Gamez & Ahmet Dogan. (2008) CD33 Detection by Immunohistochemistry in Paraffin-Embedded Tissues. American Journal of Clinical Pathology 129:2, pages 316-323.
Crossref
Daniela S. Krause & Richard A. Van Etten. (2007) Right on target: eradicating leukemic stem cells. Trends in Molecular Medicine 13:11, pages 470-481.
Crossref
I Zafir-Lavie, Y Michaeli & Y Reiter. (2007) Novel antibodies as anticancer agents. Oncogene 26:25, pages 3714-3733.
Crossref
B ten Cate, D F Samplonius, T Bijma, L F M H de Leij, W Helfrich & E Bremer. (2006) The histone deacetylase inhibitor valproic acid potently augments gemtuzumab ozogamicin-induced apoptosis in acute myeloid leukemic cells. Leukemia 21:2, pages 248-252.
Crossref
A.W. Hauswirth, S. Florian, D. Printz, K. Sotlar, M.-T. Krauth, G. Fritsch, G.-H. Schernthaner, V. Wacheck, E. Selzer, W.R. Sperr & P. Valent. (2007) Expression of the target receptor CD33 in CD34 + /CD38 ? /CD123 + AML stem cells . European Journal of Clinical Investigation 37:1, pages 73-82.
Crossref
Maria-Theresa Krauth, Alexandra Böhm, Hermine Agis, Karoline Sonneck, Puchit Samorapoompichit, Stefan Florian, Karl Sotlar & Peter Valent. (2007) Effects of the CD33-targeted drug gemtuzumab ozogamicin (Mylotarg) on growth and mediator secretion in human mast cells and blood basophils. Experimental Hematology 35:1, pages 108-116.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 23:3-4, pages 136-143.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.